1. Home
  2. PKST vs BCYC Comparison

PKST vs BCYC Comparison

Compare PKST & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PKST
  • BCYC
  • Stock Information
  • Founded
  • PKST 2008
  • BCYC 2009
  • Country
  • PKST United States
  • BCYC United Kingdom
  • Employees
  • PKST 38
  • BCYC N/A
  • Industry
  • PKST Real Estate Investment Trusts
  • BCYC Biotechnology: Pharmaceutical Preparations
  • Sector
  • PKST Real Estate
  • BCYC Health Care
  • Exchange
  • PKST Nasdaq
  • BCYC Nasdaq
  • Market Cap
  • PKST 516.3M
  • BCYC 566.5M
  • IPO Year
  • PKST N/A
  • BCYC 2019
  • Fundamental
  • Price
  • PKST $13.80
  • BCYC $8.64
  • Analyst Decision
  • PKST Buy
  • BCYC Buy
  • Analyst Count
  • PKST 2
  • BCYC 11
  • Target Price
  • PKST $15.50
  • BCYC $25.00
  • AVG Volume (30 Days)
  • PKST 121.4K
  • BCYC 312.1K
  • Earning Date
  • PKST 08-07-2025
  • BCYC 08-05-2025
  • Dividend Yield
  • PKST 6.49%
  • BCYC N/A
  • EPS Growth
  • PKST N/A
  • BCYC N/A
  • EPS
  • PKST N/A
  • BCYC N/A
  • Revenue
  • PKST $225,817,000.00
  • BCYC $25,722,000.00
  • Revenue This Year
  • PKST N/A
  • BCYC $7.35
  • Revenue Next Year
  • PKST N/A
  • BCYC N/A
  • P/E Ratio
  • PKST N/A
  • BCYC N/A
  • Revenue Growth
  • PKST 5.64
  • BCYC N/A
  • 52 Week Low
  • PKST $10.14
  • BCYC $6.10
  • 52 Week High
  • PKST $16.26
  • BCYC $28.67
  • Technical
  • Relative Strength Index (RSI)
  • PKST 54.36
  • BCYC 57.64
  • Support Level
  • PKST $13.49
  • BCYC $8.51
  • Resistance Level
  • PKST $14.16
  • BCYC $8.91
  • Average True Range (ATR)
  • PKST 0.39
  • BCYC 0.46
  • MACD
  • PKST -0.03
  • BCYC 0.09
  • Stochastic Oscillator
  • PKST 37.93
  • BCYC 57.98

About PKST Peakstone Realty Trust

Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets in majorly high-growth coastal and sunbelt markets. The company has two reportable segments: Industrial and Office. The Industrial segment consists of industrial outdoor storage properties which have a low building-to-land ratio, or low coverage, maximizing yard space for the display, movement, and storage of materials and equipment. The Office segment includes office, R&D and data center properties.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: